119 related articles for article (PubMed ID: 3429696)
1. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation.
Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ
J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol.
Garg DC; Jallad NS; Mishriki A; Chalavarya G; Kraml M; Fencik M; Weidler DJ
J Clin Pharmacol; 1987; 27(5):390-6. PubMed ID: 3693583
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
Perucca E; Grimaldi R; Gatti G; Caravaggi M; Crema F; Lecchini S; Frigo GM
Br J Clin Pharmacol; 1984 Jul; 18(1):37-43. PubMed ID: 6743489
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol.
Ohashi K; Ebihara A; Kondo K; Usami M
Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacological and pharmacokinetic observations on propranolol (long acting formulation) and bendrofluazide administered separately and concurrently to volunteers.
Nicholls DP; Harron DW; McAinsh J; Castle WM; Barker NP; Shanks RG
Br J Clin Pharmacol; 1982 Nov; 14(5):727-32. PubMed ID: 7138752
[TBL] [Abstract][Full Text] [Related]
6. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
[TBL] [Abstract][Full Text] [Related]
7. The use of long-acting propranolol ('Inderal' LA) in the management of elderly hypertensive patients.
Hamdy C; Tovey D; Baber NS; McAinsh J
Eur J Clin Pharmacol; 1982; 22(5):379-81. PubMed ID: 7117349
[TBL] [Abstract][Full Text] [Related]
8. Observations on some properties of a long-acting preparation of propranolol.
Shanks RG; Neill JD; Leahey WJ; Varma MP
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():409s-411s. PubMed ID: 540460
[TBL] [Abstract][Full Text] [Related]
9. A comparative pharmacokinetic study of conventional propranolol and long acting preparation of propranolol in patients with cirrhosis and normal controls.
Watson RG; Bastain W; Larkin KA; Hayes JR; McAinsh JA; Shanks RG
Br J Clin Pharmacol; 1987 Oct; 24(4):527-35. PubMed ID: 3689632
[TBL] [Abstract][Full Text] [Related]
10. Propranolol in cardiac arrhythmias: a comparative study of the conventional and long-acting formulations.
Kubik MM; Gill B; Dawes PM
Curr Med Res Opin; 1986; 10(4):215-20. PubMed ID: 3780285
[TBL] [Abstract][Full Text] [Related]
11. The pharmacodynamics and pharmacokinetics of conventional and long-acting propranolol in patients with moderate hypertension.
Serlin MJ; Orme ML; MacIver M; Green GJ; Sibeon RG; Breckenridge AM
Br J Clin Pharmacol; 1983 May; 15(5):519-27. PubMed ID: 6860527
[TBL] [Abstract][Full Text] [Related]
12. Propranolol and propranolol-LA in essential tremor: a double blind comparative study.
Cleeves L; Findley LJ
J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):379-84. PubMed ID: 3283296
[TBL] [Abstract][Full Text] [Related]
13. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-acting propranolol on blood pressure and heart rate in hypertensive Chinese.
Oh VM; Chia BL; Taylor EA
Br J Clin Pharmacol; 1985 Aug; 20(2):144-7. PubMed ID: 4041332
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic study of propranolol in patients with cirrhosis and portal hypertension.
Calès P; Grasset D; Ravaud A; Meskens C; Blanc M; Vinel JP; Cotonat J; Pascal JP
Br J Clin Pharmacol; 1989 Jun; 27(6):763-70. PubMed ID: 2569324
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Sica D; Frishman WH; Manowitz N
Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
[TBL] [Abstract][Full Text] [Related]
17. Propranolol pharmacokinetics and pharmacodynamics after single doses and at steady-state.
Lalonde RL; Pieper JA; Straka RJ; Bottorff MB; Mirvis DM
Eur J Clin Pharmacol; 1987; 33(3):315-8. PubMed ID: 3691620
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic comparison of two doses of long acting propranolol (80 and 160 mg) in healthy subjects.
Flouvat B; Berlin I; Cournot A; Robinet D; Duchier J; Sarmini H; Rossi A
Br J Clin Pharmacol; 1989 May; 27(5):539-45. PubMed ID: 2757878
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetic and pharmacodynamic study of four different brands of propranolol in normal volunteers.
Biswas NR; Garg SK; Kumar N; Mukherjee S; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):515-9. PubMed ID: 2583878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
